BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 14990159)

  • 1. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments].
    Lin N; Zhu P; Zhang X; Dong Y; Ren Y; Wang Y; Li W
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):766-70. PubMed ID: 12126549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
    Liu Y; Zhu P; Hu YM
    Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C; Liu QG; Yang W; Yao YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferation of specific cytotoxic T lymphocytes induced by immunoglobulin heavy chain framework region-derived antigenic nonapeptides].
    Liu Y; Zhu P; Hu YM
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):97-102. PubMed ID: 14990121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Function analysis of the family-specific CTL induced by peptides derived from IgHV gene framework region of B-cell malignance].
    Guo XL; Zhu P; Liu Y; Liu J; Zhu X
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):453-7. PubMed ID: 16383233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of fusion gene between IgGHV and IL-2 as IgHV nucleic acid vaccine against lymphoma].
    Liu H; Chang NB; Gu XC; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1160-2. PubMed ID: 17204185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine].
    Yang W; Guo C; Liu QG
    Ai Zheng; 2008 Feb; 27(2):149-54. PubMed ID: 18279611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor].
    Qing YL; Zhao JJ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):201-4. PubMed ID: 15099465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
    Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of anti-B-cell acute lymphoblastic leukemia cytotoxic T lymphocyte response against immunoglobulin heavy chain frame-derived nonapeptide].
    Liu Y; Zhu P; Hu YM
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):285-8. PubMed ID: 15949291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of GM-CSF immune accessory effects in tumor-bearing mice by direct gene immunization.
    Dou J; Hong X; Zhao F; Wang J; Chen J; Chen G
    Immunol Invest; 2006; 35(2):227-37. PubMed ID: 16698679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and expression of eukaryotic coexpression plasmid containing human MUC1 gene and GM-CSF gene].
    Yuan SF; Shi CH; Yan W; Yao Q; Li NL; Wang T; Wang L; Zhang YQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):18-20, 24. PubMed ID: 17210098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The construction and immune response of fusion DNA vaccine CRT180/HPV6E7].
    Zhao KJ; Cheng H; Xu Y; Zhu KJ; Chen ML; Zhang X; Song T; Wang Q; Chen DF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):573-7. PubMed ID: 17718414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.
    Guo H; Chen G; Lu F; Chen H; Zheng H
    Chin Med J (Engl); 2001 Mar; 114(3):317-20. PubMed ID: 11780322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epitopes recognized by cytotoxic T lymphocytes in immunoglobulin heavy chain variable regions expressed by B-cell acute lymphoblastic leukemia].
    Liu Y; Zhu P; Hu YM
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):106-10. PubMed ID: 15946551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.